Delivery Order SPE2DB20D1004-SPE2DB23FG2J1

Award Date 7/17/23
Potential Completion Date 7/18/23
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 56 tablets of Varenicline 1 mg, a prescription medication. The contract has a firm fixed price of $2,809.24 and a completion date of August 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its broader federal contracting activities with the DLA and other agencies. The company holds significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 56 tablets of the drug varenicline (0.5 mg). The contract has a firm fixed price of $5,068.69 and a completion date of November 15, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $1,084.72, is for the supply of Varenicline 1 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,302.07 firm fixed-price delivery order is for the supply of 56 tablets of the drug Varenicline 1 mg. The contract has an ultimate completion date of September 26, 2022 and was awarded on September 23, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,684.94 firm fixed-price delivery order is for the supply of 56 tablets of the medication Varenicline 0.5 mg. The award has an ultimate completion date of June 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,602.19 firm fixed price contract is for the delivery of 4,566,087,278 units of the pharmaceutical product Varenicline 1 mg Tablet in 56-count packages. The delivery order has an ultimate completion date of October 15, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.94 firm fixed-price delivery order is for the supply of 4,567,409,332 tablets of the medication Varenicline 0.5 mg, with a completion date of February 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Varenicline 1 mg tablets, with a ceiling value of $3,489.40 and a completion date of August 7, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen is the prime contractor for this award, which is associated with the company's Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $1,508.67 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565535452 VARENICLINE 1 MG TABLET 56S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The $8,248.36 firm fixed-price contract has a completion date of June 27, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG2J1
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $3,620.99, is for the supply of 56 tablets of the medication Varenicline 1 mg. The contract is a firm-fixed price delivery order with a completion date of July 18, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, covering similar medical products and prescription drugs. This delivery order was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 1:19 PM